The International Nonproprietary Names of humanized antibodies end in -zumab, as in omalizumab (see Nomenclature of monoclonal antibodies).
International Code of Zoological Nomenclature | Binomial nomenclature | Nomenclature of monoclonal antibodies | International Nomenclature of Cosmetic Ingredients | binomial nomenclature | Battery nomenclature | Retroactive nomenclature | Nucleic acid nomenclature | Nomenclature | nomenclature | International Code of Nomenclature for algae, fungi, and plants | Hantzsch–Widman nomenclature | Chlamydia antibodies | Chemical nomenclature | Anti-p62 antibodies |